TALPHERA, INC. (TLPH)

↓ Download CSV

CIK 0001427925 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, TALPHERA, INC. reported revenue of $28.0K. The company ran a net loss, with a net margin of -51035.7%. It held $29.72M in total assets against $12.68M in total liabilities.

Key ratios (FY2025)

-48157.1%
Operating margin
-51035.7%
Net margin
-83.9%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$28.0K$0$651.0K$0$378.0K$5.42M$2.29M$2.15M$8.00M
Cost of Revenue$0$571.0K$6.03M$6.81M$3.98M$10.66M$12.31M
Operating Income-$13.48M-$15.25M-$16.89M-$25.30M-$18.12M-$40.96M-$54.20M-$35.73M-$38.68M-$31.96M
Net Income-$14.29M-$13.00M-$18.40M$47.76M-$35.10M-$40.38M-$53.24M-$47.15M-$51.51M-$43.16M
EPS (Diluted)$-0.34$-0.50$-1.29$5.73$-5.86$-1.10$-0.95
Total Assets$29.72M$18.24M$20.39M$47.49M$77.89M$66.30M$91.36M$120.53M$75.55M$99.99M
Total Liabilities$12.68M$10.23M$6.29M$25.67M$113.79M$122.05M$132.77M$116.28M$112.06M$105.33M
Shareholders' Equity$17.04M$8.00M$14.11M$21.81M-$35.89M-$55.75M-$41.42M$4.25M-$36.51M-$5.34M
Cash & Equivalents$5.89M$8.86M$5.72M$15.28M$7.66M$27.27M$14.68M$87.97M$52.90M$80.31M
Operating Cash Flow-$11.36M-$12.68M-$17.49M-$28.33M-$30.00M-$38.51M-$51.18M-$29.07M-$29.77M-$29.39M
Capital Expenditures$0$100.0K$364.0K$1.83M$1.85M$3.47M$819.0K$2.40M$3.72M
Shares Outstanding49.33M17.03M16.95M8.24M6.84M98.81M79.57M78.76M50.90M45.33M